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The Department of Public Health’s (DPH) Prescription Drug Monitoring Program (PMP) serves as a repository of data for all prescription drugs dispensed 
statewide, including those prescriptions that are sought after for illicit and non-medical use and thus represent the highest potential for abuse (federal 
Schedules II – V, including certain narcotics, stimulants and sedatives). The PMP also enables prescribers and dispensers to access a patient’s 
prescription history and can be used as a clinical decision-making tool, allowing the provider to have a holistic view of the patient’s medications. 
 
When interpreting PMP county-level data, it is important to emphasize that increases or decreases in a single measure may not indicate an increase or 
decrease in prescription misuse or abuse. Put simply, use does not always equate to abuse. There are many factors that might explain an unusually high 
rate of prescribing in a given area. For instance, an area which contains a large number of residents in long-term care facilities may result a high rate of 
opioid prescribing. 
 
These datasets inform critical discussions about opioid prescribing, provide an important baseline to better inform future policy decisions and allow the 
state and stakeholders to more meaningfully measure whether policy initiatives are effective. 
 
Effective October 6, 2014, all hydrocodone combination drug (HCD) products (e.g., Vicodin) were reclassified from Schedule III to Schedule II.  This 
reclassification during the last quarter of 2014 makes comparisons over time difficult to interpret. Beginning with CY 2015 data, reports of Schedule II 
products will include all HCD prescriptions.  
 
Individuals with activity of concern "thresholds" for this report are based on a 3-month time period. MDPH also releases an annual county-level report 
that provides thresholds that are based on a 12-month time period. Although the numbers (or rates) generated may appear to be comparable, they 
represent different time periods and are NOT an apples-to-apples comparison. The results are only comparable when the thresholds (e.g., 4 different 
providers and 4 different pharmacies), time interval (e.g. over a three-month period), and drug products analyzed (e.g. Schedule II opioids) are the 
same. Meaning, the total number (or rates) of individuals who received Schedule II-V opioid prescriptions from 4 or more providers and had them filled 
at 4 or more pharmacies in a 3-month period cannot and should not be compared with the total number of individuals (or rates) who received Schedule 
II-V opioid prescriptions from 4 or more providers and had them filled at 4 or more pharmacies in a 12-month period. 
 
 
 
 
MA Prescription Monitoring Program: January 2017 – March 2017 
MA Prescription Monitoring Program County-Level Data 
Measures (2017 Quarter 1) 
 
  
County                          
(County 
classifications are by 
patient zip code; 
patient state must 
also = MA) 
Census  
Population 
Total 
Schedule II 
Opioid 
Prescriptions 
Total 
Number of 
Schedule II 
Opioid Solid 
Dosage Units 
Individuals 
Receiving 
Schedule II 
Opioid 
Prescription 
% of Individuals 
Receiving 
Schedule II Opioid 
Prescription 
 (of total 
population) 
Individuals 
with 
Activity of 
Concern 
Rate of 
Individuals 
with Activity of 
Concern  
(per 1,000) 
Barnstable 214,333 24,651 1,417,515 11,225 5.2 11 1.0 
Berkshire 127,828 14,845 818,034 6,437 5.0 8 1.2 
Bristol 556,772 72,345 4,431,990 30,672 5.5 23 0.7 
Dukes 17,299 1,716 99,947 826 4.8 < 5 NR 
Essex 776,043 74,008 4,099,309 33,909 4.4 29 0.9 
Franklin 70,601 9,852 596,478 4,063 5.8 < 5 NR 
Hampden 470,690 61,441 3,628,771 26,160 5.6 21 0.8 
Hampshire 161,292 17,177 1,091,253 7,093 4.4 10 1.4 
Middlesex 1,585,139 104,901 5,732,385 52,260 3.3 48 0.9 
Nantucket 10,925 1,072 41,342 506 4.6 0 0.0 
Norfolk 696,023 56,863 3,249,039 27,481 3.9 22 0.8 
Plymouth 510,393 55,567 3,277,644 25,630 5.0 38 1.5 
Suffolk 778,121 51,055 3,088,455 24,089 3.1 22 0.9 
Worcester 818,963 85,323 5,449,300 38,168 4.7 32 0.8 
MA 6,794,422 630,816 37,021,461 288,519 4.2 264 0.9 
 
Note 1: Individuals with activity of concern "thresholds" for this report are based ONLY on a 3-month time period; see notes on previous page; CY17-Q1 
Note 2: Counts greater than 0 but less than 5 are not reported.  Rates based on these small values also are not reported (NR). 
Note 3: Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule II opioid prescriptions during the 
specified time period. 
Note 4: PMP data are preliminary and subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by 
pharmacies. This data were extracted on 04/10/2017; Release Date: May 2017. 
Note 5: Beginning in 3rd quarter of 2016, the Department of Veterans Affairs (VA) facilities began submitting data to the MA PMP. 
Note 6: National Center for Health Statistics.  Postcensal estimates of the resident population of the United States for July 1, 2010-July 1, 2015, by year, county, single-year of 
age (0, 1, 2, .., 85 years and over), bridged race, Hispanic origin, and sex (Vintage 2015). 
 
  
 
MA Prescription Monitoring Program Data 
Trend Analyses for Schedule II Opioids Only 
 
 Registered MassPAT providers conducted over 1.5 million searches in the 1st Quarter of 2017, a 500% increase 
over the 1st Quarter of 2015 (n = 255,302 searches). 
 In the 1st Quarter of 2017 there were approximately 650,000 Schedule II opioid prescriptions reported to the MA 
PMP, a 23% decline from the 1st Quarter of 2015 (n = 844,990 Schedule II opioid prescriptions). 
 
 
 Approximately 297,000 individuals in MA received prescriptions for Schedule II opioids in the 1st Quarter of 
2017, a 24% decrease from the 1st Quarter of 2015 (n = 390,532).  
 
 
Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted 
by pharmacies. The data for the quarterly trends were extracted on 5/2/2017. 
  
 The rate of individuals with activity of concern (also referred to as multiple provider episodes) decreased from 
14.3 to 7.7 per 1,000 individuals between CY 2013 and CY 2016, a 46% reduction in activity of concern.  
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Figure 3. Rate1 of Individuals with Activity of Concern2 in MA3
2013–2016
Activity of Concern
1 Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule II 
opioid prescriptions.
2 "Activity of Concern"  is defined as an individual who received prescriptions for one or more Schedule II opioid drugs from four or 
more different prescribers and had them filled at four or more pharmacies during the specified time period.
3 Activity of concern rates include only MA Residents
